Penn Entertainment Faces Proxy Fight From Investor Citing 'Persistent Bad Judgment'
The investor, New York-based HG Vora, has never before launched a proxy battle. It cited “Years of Poor Judgment, Failed Transactions, and Value Destructive Actions” as the rationale behind its move to do so now in a statement released Wednesday.
Activist investor Ananym Capital Management plans to nominate as many as half a dozen directors to the board at Henry Schein ...
Following a tough opening salvo from Starboard Value last fall, Pfizer is getting a chance to catch its breath in the ...
HG Vora is launching a proxy fight at Penn Entertainment (PENN) and is submitting nominations for three independent board seats, Lauren Thomas of Wall Street Journal reports, citing people ...
Air Products and Chemicals shareholders on Thursday handed activist investor Mantle Ridge Capital Management victory by electing three of its four proposed director candidates to the industrial gases ...
Shares of Pfizer PFE rose nearly 3% on Monday following a report issued by Bloomberg, which stated that activist investor Starboard did not nominate any director to Pfizer’s board ahead of Jan. 25.
Pfizer Inc (NYSE:PFE) shares are trading higher Monday. Some of the optimism may be surrounding activist Starboard Value's ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback